CVClient

川崎 優子

カワサキ ユウコ  (Yuko Kawasaki)

基本情報

所属
兵庫県立大学 看護学部 教授

通称等の別名
兵庫県立大学 看護学部
J-GLOBAL ID
200901054972456447
researchmap会員ID
5000061994

研究キーワード

 2

論文

 46
  • Yuko Kawasaki, Tamotsu Sudo, Kazuo Tamura, Saki Hinoshita, Kayoko Hasuoka, Satoko Miyawaki, Nao Matsutani, Akira Hirasawa, Atsuko Uchinuno
    Clinics and practice 14(5) 2105-2115 2024年10月12日  
    (1) Background: The number of patients with cancer undergoing cancer genome profiling is increasing; however, it remains unclear how accurately they understand the details of the tests and treatments. This study aimed to clarify the awareness of cancer genome profiling tests among patients with cancer who visited cancer genome medical clinics. (2) Methods: A questionnaire survey was conducted on awareness, anxiety, sources of information, and psychological states concerning cancer genome profiling tests. (3) Results: In total, 265 patients with cancer (117 men, 142 women, 6 no response, average age of 58.29 ± 11.9 years) were included in the study, of which 218 (82.3%) were aware of the term "cancer genomic medicine" and 90 (34.0%) were aware of its details. Thus, only a few respondents understood that cancer genome profiling tests facilitate the discovery of secondary findings and of genes associated with hereditary tumors. Regarding their psychological state when visiting the cancer genome clinic, the respondents were anxious about standard treatment and prognosis limits. (4) Conclusions: From the viewpoint of advance care planning, we suggest that medical professionals build a support system that links palliative care and cancer treatment and coordinates genetic counseling at an early stage.
  • 松本 綾奈, 川崎 優子
    兵庫県立大学看護学部・地域ケア開発研究所紀要 31 13-27 2024年3月  査読有り
  • 永島 志, 川崎 優子
    兵庫県立大学看護学部・地域ケア開発研究所紀要 31 1-12 2024年3月  査読有り
  • Yuko Kawasaki, Kei Hirai, Manabu Nii, Yoshiyuki Kizawa, Atsuko Uchinuno
    Cancer diagnosis & prognosis 4(1) 57-65 2024年  
    BACKGROUND/AIM: Patients diagnosed with cancer are expected to choose one or more treatment modalities after receiving corresponding explanations of the options. When making these choices, patients consider the effects of treatment and aspects related to their quality of life. These concerns can cause confusion and conflict owing to the complicated information provided by medical caregivers. The objective of the study was to identify perceptions of cancer treatment in patients with cancer and the decision-making factors affecting their treatment choices. PATIENTS AND METHODS: In this observational (cross-sectional) study, an online questionnaire survey was administered to 194 Japanese cancer patients with treatment experience. Patient information, perceptions of explanations provided by healthcare professionals, treatment views, and reasons for treatment decisions were subjected to a simple tabulation. Content and factor analysis was conducted to determine important treatment selection elements. RESULTS: Regarding treatment perception, 60.3% of respondents (n=117) considered treatment a financial and family burden, 47.4% (n=92) had concerns about physical pain, and 40.2% (n=78) were worried about increased stress. Regarding decision-making quality, 95.9% determined their preferred treatment within one week, 49.0% reported difficulties in making their decisions, and 83.0% chose their treatment themselves. Major decisive factors were prolonging life, opinions of medical staff, and accepting treatment risks (68.0%, 68.6%, and 60.3% of patients, respectively). The main attitudes toward treatment were anxiety, expectations of benefit, and expectations of support and care. CONCLUSION: SDM should enable patients to visualize the changes that their bodies will experience and include discussions on prognosis. Psychological care should be prioritized to alleviate anxiety and improve readiness for decision-making; attention should be paid to the extent and timing of information provision.
  • Yuko Kawasaki, Kei Hirai, Manabu Nii, Yoshiyuki Kizawa, Atsuko Uchinuno
    Future oncology (London, England) 2023年10月31日  
    Background: We investigated factors involved in decision-making support provided by physicians, nurses, pharmacists and medical and psychiatric social workers involved in cancer care. Materials & methods: A questionnaire survey on decision-making support was conducted. The level of clinician support was classified as 'supporting patients' 'decision-making process regarding cancer treatment', 'no support for patients' 'decision-making process regarding cancer treatment' or 'team-based support for patients' 'decision-making process regarding cancer treatment'. Results: Physicians estimated that 83.7% of patients made a cancer treatment decision within 1 week, but 45.4% of patients had difficulty making a decision. Conclusion: Medical personnel should support patients who have difficulty making decisions, establish a screening method to identify those needing support and develop a system providing decision-making support through interprofessional work.

MISC

 89
  • 日下 咲, 須藤 保, 川崎 優子
    日本がん看護学会誌 38 2024年3月  最終著者
  • 林 直子, 沖村 愛子, 小笠 美春, 鈴木 久美, 雄西 智恵美, 入澤 裕子, 内田 恵, 田代 真理, 遠藤 久美, 川崎 優子, 藤田 佐和, 渡邉 眞理, 日本がん看護学会令和4年度将来構想推進委員会
    日本がん看護学会誌 38 1-6 2024年1月  
  • 川崎 優子
    日本放射線看護学会誌 11(1) 26-28 2023年6月  
  • 川崎 優子
    日本遺伝カウンセリング学会誌 44(2) 69-69 2023年6月  
  • 今井 芳枝, 阿部 彰子, 村上 好恵, 武田 祐子, 川崎 優子, 板東 孝枝, 高橋 亜希, 井上 勇太, 阪本 朋香, 吉田 加奈子
    遺伝性腫瘍 22(3) 68-74 2023年2月  
    本研究は,遺伝性乳癌卵巣癌症候群(hereditary breast and ovarian cancer syndrome;HBOC)と診断された乳癌罹患患者のリスク低減卵管卵巣摘出術(risk reducing birateral salpingo-oophorectomy;RRSO)後の思いを明らかにすることを目的とした.対象者は,HBOCと診断された乳癌罹患患者でRRSO後の20歳以上の成人患者12名とし,半構造化面接方法でデータ収集をした.結果,HBOCと診断された乳癌罹患患者のRRSO後の思いとして【がんという恐怖から解き放たれて安らいでいる】【タイミングがよかったので、手術を決心できた】【後続の人のために自分の手術経験を役立てる】【RRSOが終わった今だからこそ身内のがんに向き合う】【手術をしても自分の状態を思い煩う】【手術で卵巣を取り除いたことに負い目がある】の6つのカテゴリーが導き出された.HBOCと診断された乳癌罹患患者はRRSOの意義を十分に理解しており、RRSOは自身のがんのリスク低減だけではなく身内のためでもあり,HBOCの家系が関わる遺伝の特徴が見出されていた.一方で、RRSO後にも自分の身体状態に対して不安や心配などネガティブな心情を持ち続けていたことが示された.(著者抄録)

書籍等出版物

 15

講演・口頭発表等

 67

所属学協会

 9

共同研究・競争的資金等の研究課題

 31